Synjardy is considered more comprehensive than metformin alone because it combines metformin with an additional medication, empagliflozin, thereby acting through more mechanisms to lower blood sugar levels.
Understanding the Mechanisms
While metformin is an effective medication that reduces blood sugar through various pathways, Synjardy offers an expanded approach. Synjardy is a combination medication that includes both metformin and empagliflozin.
- Metformin: This drug works in multiple ways to help lower your blood sugar.
- Synjardy: By containing both metformin and empagliflozin, Synjardy works through a greater number of mechanisms compared to metformin used by itself.
The Advantage of Dual Action
The inclusion of empagliflozin in Synjardy means it can address blood sugar management from more angles than metformin could alone. This dual-component approach provides a broader therapeutic effect for individuals managing their blood sugar levels.
For more detailed information on Synjardy, you can refer to resources like Medical News Today.
